May 7 |
Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
|
May 7 |
Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates
|
May 7 |
Myriad Genetics GAAP EPS of -$0.29 beats by $0.01, revenue of $202.2M beats by $8.95M
|
May 7 |
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
|
May 7 |
Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
|
May 7 |
Myriad Genetics (NASDAQ:MYGN) shareholders have endured a 26% loss from investing in the stock five years ago
|
May 6 |
Myriad Genetics Q1 2024 Earnings Preview
|
Apr 30 |
Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024
|
Apr 24 |
Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
|
Apr 17 |
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor
|